INMED PHARMACEUTICALS (Germany) Buy Hold or Sell Recommendation
| MWG0 Stock | 4.14 0.75 15.34% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding INMED PHARMACEUTICALS INC is 'Strong Sell'. Macroaxis provides INMED PHARMACEUTICALS buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MWG0 positions.
Check out INMED PHARMACEUTICALS Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in INMED Stock please use our How to Invest in INMED PHARMACEUTICALS guide. Note, we conduct extensive research on individual companies such as INMED and provide practical buy, sell, or hold advice based on investors' constraints. INMED PHARMACEUTICALS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
INMED |
Execute INMED PHARMACEUTICALS Buy or Sell Advice
The INMED recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on INMED PHARMACEUTICALS INC. Macroaxis does not own or have any residual interests in INMED PHARMACEUTICALS INC or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute INMED PHARMACEUTICALS's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
INMED PHARMACEUTICALS Trading Alerts and Improvement Suggestions
| INMED PHARMACEUTICALS is way too risky over 90 days horizon | |
| INMED PHARMACEUTICALS appears to be risky and price may revert if volatility continues |
INMED PHARMACEUTICALS Returns Distribution Density
The distribution of INMED PHARMACEUTICALS's historical returns is an attempt to chart the uncertainty of INMED PHARMACEUTICALS's future price movements. The chart of the probability distribution of INMED PHARMACEUTICALS daily returns describes the distribution of returns around its average expected value. We use INMED PHARMACEUTICALS INC price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of INMED PHARMACEUTICALS returns is essential to provide solid investment advice for INMED PHARMACEUTICALS.
| Mean Return | 0.27 | Value At Risk | -11.29 | Potential Upside | 15.31 | Standard Deviation | 9.90 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of INMED PHARMACEUTICALS historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
INMED PHARMACEUTICALS Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to INMED PHARMACEUTICALS or INMED sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that INMED PHARMACEUTICALS's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a INMED stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.31 | |
β | Beta against Dow Jones | -2.06 | |
σ | Overall volatility | 10.01 | |
Ir | Information ratio | 0.02 |
INMED PHARMACEUTICALS Volatility Alert
INMED PHARMACEUTICALS INC is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure INMED PHARMACEUTICALS's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact INMED PHARMACEUTICALS's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.INMED PHARMACEUTICALS Fundamentals Vs Peers
Comparing INMED PHARMACEUTICALS's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze INMED PHARMACEUTICALS's direct or indirect competition across all of the common fundamentals between INMED PHARMACEUTICALS and the related equities. This way, we can detect undervalued stocks with similar characteristics as INMED PHARMACEUTICALS or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of INMED PHARMACEUTICALS's fundamental indicators could also be used in its relative valuation, which is a method of valuing INMED PHARMACEUTICALS by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare INMED PHARMACEUTICALS to competition |
| Fundamentals | INMED PHARMACEUTICALS | Peer Average |
| Number Of Employees | 13 | 18.84 K |
INMED PHARMACEUTICALS Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as INMED . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.85 | |||
| Day Median Price | 4.14 | |||
| Day Typical Price | 4.14 | |||
| Price Action Indicator | (0.37) | |||
| Period Momentum Indicator | (0.75) |
About INMED PHARMACEUTICALS Buy or Sell Advice
When is the right time to buy or sell INMED PHARMACEUTICALS INC? Buying financial instruments such as INMED Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having INMED PHARMACEUTICALS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Trump Equities Thematic Idea Now
Trump Equities
Stocks that have significantly increased in valuation since Trump was elected president of the United States. The Trump Equities theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Trump Equities Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in INMED Stock
INMED PHARMACEUTICALS financial ratios help investors to determine whether INMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in INMED with respect to the benefits of owning INMED PHARMACEUTICALS security.